icon-folder.gif   Conference Reports for NATAP  
 
  63rd Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 9-12 2012
Back grey_arrow_rt.gif
 
 
 
Six Years of Treatment With Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection Is Safe and Well Tolerated and Associated With Sustained Virological, Biochemical, and Serological Responses With No Detectable Resistance
 
 
  Reported by Jules Levin
AASLD Nov 9-13 2012 Boston
 
Patrick Marcellin1, Maria Buti2, Edward Gane3, Naoky Tsai4, William Sievert5, Ira M. Jacobson6, George Germanidis7, Phillip Dinh8, John F. Flaherty8, Kathryn M. Kitrinos8, John G. McHutchison8, Nezam H. Afdhal9 1H˘pital Beaujon, Clichy, France; 2Hospital General Universitari Vall d'Hebron and Ciberehd, Barcelona, Spain; 3Auckland City Hospital, Auckland, New Zealand; 4University of Hawaii at Manoa, Honolulu, HI, United States; 5Monash University and Monash Medical Centre, Melbourne, VIC, Australia; 6Weill Cornell Medical College, New York, NY, United States; 7AHEPA University Hospital, Aristotle University Medical School, Thessaloniki, Greece; 8Gilead Sciences, Inc., Foster City, CA, United States; 9Beth Israel Deaconess Medical Center, Boston, MA, United States

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif